RU95115500A - MEANS FOR PREVENTIVE, SUPPORTING AND RESTORATIVE THERAPIES FOR DEVELOPING DURING AGING AND / OR UNDER INFLUENCE OF PATHOGENIC FACTORS OF PATHOLOGIES RELATED TO DYSTROPHIC AND ORGENERANIC TENGENISMAN - Google Patents
MEANS FOR PREVENTIVE, SUPPORTING AND RESTORATIVE THERAPIES FOR DEVELOPING DURING AGING AND / OR UNDER INFLUENCE OF PATHOGENIC FACTORS OF PATHOLOGIES RELATED TO DYSTROPHIC AND ORGENERANIC TENGENISMANInfo
- Publication number
- RU95115500A RU95115500A RU95115500/14A RU95115500A RU95115500A RU 95115500 A RU95115500 A RU 95115500A RU 95115500/14 A RU95115500/14 A RU 95115500/14A RU 95115500 A RU95115500 A RU 95115500A RU 95115500 A RU95115500 A RU 95115500A
- Authority
- RU
- Russia
- Prior art keywords
- dystrophic
- tengenisman
- orgeneranic
- preventive
- supporting
- Prior art date
Links
- 230000032683 aging Effects 0.000 title claims 2
- 230000001717 pathogenic Effects 0.000 title claims 2
- 238000002560 therapeutic procedure Methods 0.000 title claims 2
- 230000003449 preventive Effects 0.000 title 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N water-d2 Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 claims 2
- 230000003412 degenerative Effects 0.000 claims 1
- 210000000056 organs Anatomy 0.000 claims 1
- 230000003319 supportive Effects 0.000 claims 1
- 210000001519 tissues Anatomy 0.000 claims 1
Claims (1)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU95115500A RU2083210C1 (en) | 1995-09-13 | 1995-09-13 | Agent for prophylaxis, supporting and recovering therapy for control of pathology developing at ageing and/or pathogenic factors effect associated with dystrophic and degenerative organ and tissue alterations |
PCT/RU1996/000255 WO1997009991A1 (en) | 1995-09-13 | 1996-09-10 | Agent for use in the prevention and treatment of disorders associated with various types of ageing |
EP96931314A EP0893123A4 (en) | 1995-09-13 | 1996-09-10 | Agent for use in the prevention and treatment of disorders associated with various types of ageing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU95115500A RU2083210C1 (en) | 1995-09-13 | 1995-09-13 | Agent for prophylaxis, supporting and recovering therapy for control of pathology developing at ageing and/or pathogenic factors effect associated with dystrophic and degenerative organ and tissue alterations |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2083210C1 RU2083210C1 (en) | 1997-07-10 |
RU95115500A true RU95115500A (en) | 1997-09-10 |
Family
ID=20171820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU95115500A RU2083210C1 (en) | 1995-09-13 | 1995-09-13 | Agent for prophylaxis, supporting and recovering therapy for control of pathology developing at ageing and/or pathogenic factors effect associated with dystrophic and degenerative organ and tissue alterations |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0893123A4 (en) |
RU (1) | RU2083210C1 (en) |
WO (1) | WO1997009991A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007031397A1 (en) * | 2007-07-05 | 2009-01-08 | D2O Bioscience Group Ltd. | Use of deuterium oxide for the treatment of virus-based diseases of the skin |
ES2459198T3 (en) * | 2008-04-20 | 2014-05-08 | D2 Bioscience Group Ltd | Use of deuterium oxide as an elastase inhibitor |
DE102009003942A1 (en) | 2009-01-07 | 2010-07-08 | D2O Biosience Group Ltd., Hamilton | Use of deuterium oxide for the treatment of virus-based diseases of the eye |
DE102009003992A1 (en) * | 2009-01-07 | 2010-07-08 | D2O Biosience Group Ltd., Hamilton | Use of deuterium oxide for the treatment of virus-based diseases of the respiratory tract |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5223269A (en) * | 1989-08-31 | 1993-06-29 | Andrejs Liepins | Methods and composition for the treatment of hypertension |
HU208084B (en) * | 1991-10-31 | 1993-08-30 | Hyd Kutato Fejlesztoe Kft | Process for producing compositions suitable for curing tumorous diseases |
DE69434598T3 (en) * | 1993-07-29 | 2010-07-29 | The United States Of America Represented By The Secretary, Department Of Health And Human Services | Use of paclitaxel and its derivatives for the manufacture of a medicament for the treatment of restenosis |
DE4427690A1 (en) * | 1994-08-04 | 1996-02-08 | Bogdahn Ulrich Prof | Pharmaceutical composition containing deuterium as a cytostatic or tumor therapeutic |
GB2293100A (en) * | 1994-09-15 | 1996-03-20 | Medeva Europ Ltd | Pharmaceutical compositions with deuterium oxide |
-
1995
- 1995-09-13 RU RU95115500A patent/RU2083210C1/en not_active IP Right Cessation
-
1996
- 1996-09-10 WO PCT/RU1996/000255 patent/WO1997009991A1/en not_active Application Discontinuation
- 1996-09-10 EP EP96931314A patent/EP0893123A4/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2007001I1 (en) | MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES | |
NO986052L (en) | Anticonvulsant sulphamate derivatives for use in the treatment of obesity | |
AU535300B2 (en) | Creping tissue | |
CA2126083A1 (en) | Use of app modulators for the manufacture of a medicament for the treatment of amyloidosis | |
GB2301366A (en) | Antibodies against E-selectin | |
EP0624344A3 (en) | Diathermy handpiece with endoscopic probe. | |
ES482097A1 (en) | Novel acyl-derivatives of carnitine and process for their preparation | |
ES2196082T3 (en) | ANALAGOS OF THE QUERATINOCIT GROWTH FACTOR. | |
CA2164951A1 (en) | Lipoxin compounds | |
ES2193233T3 (en) | USE OF AMIODIPINE, A SALT OF THE SAME OR PHELODIPINE IN COMBINATION WITH AN ACE INHIBITOR IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF NON-ISCHEMICAL CONJUNCTIVE HEART FAILURE. | |
RU95115500A (en) | MEANS FOR PREVENTIVE, SUPPORTING AND RESTORATIVE THERAPIES FOR DEVELOPING DURING AGING AND / OR UNDER INFLUENCE OF PATHOGENIC FACTORS OF PATHOLOGIES RELATED TO DYSTROPHIC AND ORGENERANIC TENGENISMAN | |
DK317285D0 (en) | PHARMACOLOGICAL EFFECTS (PYRROL-1-YL) -PHENYL-DIHYDROPYRIDAZINONES AND PROCEDURES FOR PREPARING IT | |
FI965094A0 (en) | 2,4,6-Triiodo-5-substituted aminoisophthalate esters useful as contrast agents in medical diagnostic imaging | |
AU1086888A (en) | Primary biliary cirrhosis autoantigen | |
NO892408L (en) | PROCEDURE FOR AA HOME VOLTAGE CORROSION PREPARATION IN AUSTENITIAN ALLOYS. | |
UA42797C2 (en) | Quinolone- and naphthyridonecarboxylic acid derivatives and isoindole derivatives for preparation thereof | |
DE3268716D1 (en) | Peptides and process for their preparation | |
NO960347L (en) | Use of benzydamide in the treatment of pathological conditions caused by TNF | |
TR199501530A1 (en) | Kit for use in the therapeutic cycle in the treatment of osteoporosis. | |
CA2214675A1 (en) | Methods and compositions for sedating, anaesthetising and euthanising aquatic organisms | |
DK0726942T3 (en) | Foam cells monoclonal antibodies and their pharmaceutical and diagnostic use | |
IT1225800B (en) | DOUBLE POLARIZER, FOR THE OBSERVATION OF CINESCOPES IN GENERAL | |
ITPD950124A0 (en) | PROCEDURE FOR THE STERILIZATION OF CORK STOPS | |
RU95117476A (en) | NATURAL SKIN OVER | |
IT8322170A0 (en) | COMPOUNDS SUITABLE FOR THE THERAPEUTIC TREATMENT OF BILIARY ALTERATIONS, PARTICULARLY OF LITHOGEN BILE AND CHOLESTEROL STONES AND PHARMACEUTICAL COMPOSITIONS THEY CONTAIN. |